Schonmei Lee

Schonmei Lee has a diverse work experience in the medical field. Currently, they are serving as the Medical Director of Ophthalmology at 4D Molecular Therapeutics since July 2021. Prior to this, they worked at Santen as an Associate Director from October 2019 to June 2021 and as a Drug Safety Physician from February 2017 to September 2019.

Previously, Lee had a role as a Cataract and Glaucoma Surgeon at Turner Eye Institute. During their time there in 2015 and 2016, they performed various surgeries and built strong relationships with local optometrists and primary care physicians to drive business and referrals.

From July 2014 to June 2015, Lee worked as a Glaucoma Clinical Fellow at UCSF. Here, they developed expertise in glaucoma management while utilizing advanced technologies and managing day-to-day clinical affairs.

Lee began their medical career as a Resident in Ophthalmology at Baylor College of Medicine from July 2011 to June 2014. During this time, they received comprehensive training in various ophthalmological specialties and conducted multiple studies on cataract surgery outcomes.

Before specializing in ophthalmology, Lee served as a Resident in Internal Medicine at The New York Hospital Medical Center of Queens from July 2010 to June 2011. In this role, they managed patients from admission to discharge and led interdisciplinary teams.

Overall, Schonmei Lee's work experience highlights their expertise and accomplishments in ophthalmology, specifically in glaucoma management and cataract surgery outcomes research.

Schonmei Lee pursued their education with a bachelor's degree in Biology, General from Harvard University, which they completed between the years 2002 and 2006. Schonmei furthered their academic accomplishments by attending Columbia University Vagelos College of Physicians and Surgeons from 2006 to 2010, earning a Doctor of Medicine (MD) degree. However, no specific field of study was mentioned for their MD program.